EPLAW PATENT BLOG

UK – MSD v. Shionogi

Posted: December 21st, 2016

Merck Sharp and Dohme Limited v Shionogi & Co. Limited, High Court of England and Wales (Arnold J), 25 November 2015, Neutral Citation Number [2016] EWHC 2989 (Pat) The claimant, Merck, sought revocation of Shionogi’s EP(UK) 1 422 218. The defendant, Shionogi, counterclaimed for infringement by Merck’s integrase inhibitor raltegravir, marketed as Isentress. Shionogi made […]

READ MORE

NL – Hewlett-Packard v. Benson Image

Posted: December 13th, 2016

Hewlett-Packard Development Company, L.P. (“HP”) v. Benson Image B.V., Top Printing B.V. and Agiostar B.V. (“Benson”), District Court of The Hague, the Netherlands, 30 November 2016, Case number 504637 / HA ZA 16-125 HP is the owner of European Patent EP 01 737 669 for a ‘fluid ejection device’, applied for on 6 April 2005 […]

READ MORE

UK – Nicocigs v. Fontem

Posted: September 13th, 2016

Nicocigs Limited v. Fontem Holdings 1 BV, UK Patents Court, Mr John Baldwin QC, 2 September 2016, 2016 EWHC 2161 (Pat) In this action Nicocigs sought to revoke European Patent (UK) 2 022 349 and/or a declaration that its products did not infringe the patent.  The patent concerned electronic cigarettes, a market that has expanded […]

READ MORE

UK – GlaxoSmithKline v Wyeth Holdings

Posted: May 20th, 2016

GlaxoSmithKline UK Limited v Wyeth Holdings LLC, High Court of Justice of England & Wales (Patents Court), London, UK, Carr J, 12 May 2016, Neutral Citation Number: [2016] EWHC 1045 (CH) Carr J has upheld the validity of Wyeth’s patent EP(UK) 2,343,308 relating to a combination product comprising a 2086 protein and a PorA protein […]

READ MORE

NL – AstraZeneca v. Resolution

Posted: March 9th, 2016

Astrazeneca and Shionogi v Resolution, Court of Appeal the Hague, the Netherlands, 16 February 2016, Case no. 200.174.337/01, with thanks to Willem Hoyng, Jeroen den Hartog en Judith Krens, HOYNG ROKH MONEGIER, for sending in the judgment and translation in English Scope of protection. The patent (SPC) in suit relates to a new active substanse […]

READ MORE